4
Changes in Ownership
Anebulo Pharmaceuticals, Inc. Filed Acc 0001493152-22-003365
Options or other derivatives
- Chief Executive Officer acquired 625,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ALLEN SIMON Chief Executive Officer | 2022-02-07 | Grant or award · Option to purchase Common Stock | +625,000 | 625,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…